Your browser doesn't support javascript.
loading
Anti-cancer activity, and molecular docking of novel hybrid heterocyclic steroids revealed promising anti-hepatocellular carcinoma agent: Implication of cyclin dependent kinase-2 pathway.
Tantawy, Mohamed A; Shalby, Aziza B; Barnawi, Ibrahim Omar; Kattan, Shahad W; Abd-Rabou, Ahmed A; Elmegeed, Gamal A.
Affiliation
  • Tantawy MA; Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt; Stem Cells Lab, Center of Excellence for Advanced Sciences, National Research Centre, Dokki, Cairo, Egypt. Electronic address: mohamed_tantawy@daad-alumni.de.
  • Shalby AB; Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt; Stem Cells Lab, Center of Excellence for Advanced Sciences, National Research Centre, Dokki, Cairo, Egypt.
  • Barnawi IO; Department of Biological Sciences, Faculty of Science, Taibah University, Al-Madinah Al-Munawwarah, 41321, Saudi Arabia.
  • Kattan SW; Medical Laboratory Department, College of Applied Medical Sciences, Taibah University, Yanbu, Saudi Arabia.
  • Abd-Rabou AA; Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt; Stem Cells Lab, Center of Excellence for Advanced Sciences, National Research Centre, Dokki, Cairo, Egypt.
  • Elmegeed GA; Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt. Electronic address: gamalae@hotmail.com.
Steroids ; 193: 109187, 2023 05.
Article in En | MEDLINE | ID: mdl-36736802

Full text: 1 Database: MEDLINE Main subject: Steroids, Heterocyclic / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Steroids, Heterocyclic / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Limits: Humans Language: En Year: 2023 Type: Article